MedTech in Belgium: the impact of the EU-MDR on your day-to-day business

MedTech in Belgium : Understanding the current landscape and the impact of the EU-MDR on your day-to-day business

The MedTech sector is emerging and growing a community mainly composed of vibrant small companies very active in research and innovation.

The EU-MD regulation (2017/745) is now into force since May 2021 with requirements which need to be well understood to successfully bring your health innovations to the patients.

For their 3rd joint webinar,  BeCro, BioWin and flanders.bio invite you to know more about the MedTech landscape in Belgium and to learn the important points you need to know on the impact of this EU-MDR on your clinical development. 

PROGRAM: 

✔️ Introduction. Willem Dhooge, Co-General Manager, flanders.bio

✔️ The current MedTech landscape in Belgium. Marnix Denys, Managing Director, beMedTech

✔️ The new MDR and its challenges. Ruth Beckers, Coordinator MedTech Flanders

✔️ Clinical investigations under the new MDR. Steve Eglem, Head of Unit Clinical investigation & unmet Medical Needs, FAMHP – FAGG – AFMPS

✔️ Questions & Answers. Marianne Ghyoot, Director Research & Innovation, BioWin

This webinar is offered free of charge for members

For more information or any questions, please contact Marine Di Vincenzo (marine.divincenzo@biowin.org)

- The link to join the webinar will be sent to you the day before the event -

Limited seats available!